Sa2082 SGLT2 INHIBITOR THERAPY REDUCES ARRHYTHMIA BURDEN AND ICD SHOCKS IN MASLD PATIENTS WITH HFPEF AND ATRIAL FIBRILLATION: A MULTI-CENTER REAL-WORLD STUDY | Synapse
Sa2082 SGLT2 INHIBITOR THERAPY REDUCES ARRHYTHMIA BURDEN AND ICD SHOCKS IN MASLD PATIENTS WITH HFPEF AND ATRIAL FIBRILLATION: A MULTI-CENTER REAL-WORLD STUDY
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.